By Kirk Stokel
Little known to the general public is the silent epidemic of non-alcoholic
fatty liver disease or NAFLD, which afflicts up to 40% of all Americans.1 NAFLD
particularly targets those who carry around excess weight. For the nearly 70%
of Americans who are overweight or obese,2 that figure rises to a shocking
50-100%.3,4
Ominously, NAFLD sets the stage for a progression of lethal diseases that can include cancer, atherosclerosis, and diabetes.5,6 Risk of death from all causes skyrockets more than four-fold in NAFLD sufferers - and more than eight-fold for early cardiac death.7
Because of both physician and patient ignorance, most victims of NAFLD are entirely unaware they have it.
No drug can halt this widespread disease's potentially lethal progress.3
The exciting news is scientists have recently identified a novel intervention to halt two of NAFLD's core pathologic processes - lipid peroxidation, wherein excess liver fat turns rancid under continuous assault from free radicals, and rampant oxidative damage from disease-induced mitochondrial dysfunction. Readmore…
Ominously, NAFLD sets the stage for a progression of lethal diseases that can include cancer, atherosclerosis, and diabetes.5,6 Risk of death from all causes skyrockets more than four-fold in NAFLD sufferers - and more than eight-fold for early cardiac death.7
Because of both physician and patient ignorance, most victims of NAFLD are entirely unaware they have it.
No drug can halt this widespread disease's potentially lethal progress.3
The exciting news is scientists have recently identified a novel intervention to halt two of NAFLD's core pathologic processes - lipid peroxidation, wherein excess liver fat turns rancid under continuous assault from free radicals, and rampant oxidative damage from disease-induced mitochondrial dysfunction. Readmore…
No comments:
Post a Comment